Scarica l'app Stockscreener
1.62
15.18%
-0.29
Dopo l'orario di chiusura:
1.65
0.03
+1.85%
Precedente Chiudi:
$1.91
Aprire:
$1.81
Volume 24 ore:
101.24K
Relative Volume:
0.62
Capitalizzazione di mercato:
$56.14M
Reddito:
$1.82M
Utile/perdita netta:
$-267.63M
Rapporto P/E:
-0.0803
EPS:
-20.1639
Flusso di cassa netto:
$-50.53M
1 W Prestazione:
-20.59%
1M Prestazione:
-13.83%
6M Prestazione:
-47.06%
1 anno Prestazione:
-91.83%
Intervallo 1D:
$1.62
$1.859
Intervallo di 1 settimana:
$1.62
$2.08
Portata 52W:
$1.62
$21.23
Cibus Inc Stock (CBUS) Company Profile
Nome
Cibus Inc
Settore
Industria
Telefono
(858) 450-0008
Indirizzo
6455 NANCY RIDGE DRIVE, SAN DIEGO
Confronta CBUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.62 | 56.14M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 125.55B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 67.78B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 36.24B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.99B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.77B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-19 | Ripresa | Canaccord Genuity | Buy |
| 2023-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Ripresa | Canaccord Genuity | Buy |
Cibus Inc Borsa (CBUS) Ultime notizie
Corient Private Wealth LLC Sells 60,000 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Charles Schwab Investment Management Inc. Sells 7,726 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline - Investing.com Australia
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for Cibus Q1 Earnings - MarketBeat
HC Wainwright Reiterates Buy Rating for Cibus (NASDAQ:CBUS) - MarketBeat
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026 - MSN
What is HC Wainwright’s Forecast for Cibus Q1 Earnings? - Defense World
Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright - Defense World
Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Earnings Call: Strategic Progress Amid Challenges - TipRanks
Cibus (NASDAQ:CBUS) Posts Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - Yahoo Finance
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc. Reports Progress in Gene Editing and Financial Results - TipRanks
Cibus: Q4 Earnings Snapshot - mySA
Earnings call transcript: Cibus Inc. Q4 2024 focuses on innovation and cost-saving - Investing.com India
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus: Q4 Earnings Snapshot -March 20, 2025 at 06:00 pm EDT - MarketScreener
Cibus Inc. (CBUS) reports earnings - Quartz
Cibus Reports Fourth Quarter Financial Results And Provides Business Update -March 20, 2025 at 04:54 pm EDT - Marketscreener.com
Cibus, Inc. SEC 10-K Report - TradingView
Cibus Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - The Manila Times
Cibus, Inc. Supports EU Legislation Advancing New Genomic Techniques for Sustainable Agriculture - Nasdaq
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - TradingView
Major Breakthrough: EU Set to Revolutionize Agriculture with New Gene Editing Framework - Stock Titan
Cibus director Gerhard Prante sells shares worth $6,106 - MSN
Cibus (CBUS) to Release Quarterly Earnings on Thursday - MarketBeat
Cibus (CBUS) Projected to Post Earnings on Thursday - Defense World
Cibus Achieves Another Milestone for a Durable White Mold Resistance Trait in Canola - CropLife
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call - The Manila Times
Cibus, Inc. to Report Fourth Quarter 2024 Financial Results on March 20, 2025 - Nasdaq
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close - Bluefield Daily Telegraph
Agricultural Biotech Leader Cibus Sets Q4 Earnings Date: Key Gene Editing Updates Expected - StockTitan
13,000 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by IFP Advisors Inc - Defense World
Cibus Inc (CBUS) Shares Soar Above 1-Year High - The News Heater
Cibus’s Strategic Advancements and Leadership Transition Drive Buy Rating - TipRanks
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola - The Manila Times
Can Cibus' Gene-Edited Canola Traits Revolutionize Crop Disease Management? - StockTitan
Cibus Announces Leadership Transition and CEO Succession Plan - Seed World
Cibus, Inc. Announces CEO Changes -February 28, 2025 at 08:30 am EST - Marketscreener.com
Cibus Appoints Peter Beetham as Interim CEO - TipRanks
Cibus Announces Leadership Change and CEO Succession Plan - The Manila Times
Cibus Inc Azioni (CBUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):